Breakthrough Chemistry, Inc. (BKTH) fair value: what the stock is really worth
We calculate from audited financials what Breakthrough Chemistry, Inc. is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Jul 15, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch Breakthrough Chemistry, Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.
How to read this chart
60‑month range $0.0320 – $0.6600 · fair‑value band $0.0200 – $0.0500 · the $0.0897 price screens above the $0.0300 fair value. Dashed = 300-day average. As of Jul 15, 2026.
Follow Breakthrough Chemistry in your weekly email
Every Wednesday you see whether Breakthrough Chemistry is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Breakthrough Chemistry, Inc. develops compounds and formulations that defy the norms prevalent in chemical industries. The company's chemistry platform offers solutions for food security and spoilage reduction, natural resource conservation, personal hygiene, protective coatings, odor elimination, and chemical neutralization. Breakthrough Chemistry, Inc.
Show more
Breakthrough Chemistry, Inc. develops compounds and formulations that defy the norms prevalent in chemical industries. The company's chemistry platform offers solutions for food security and spoilage reduction, natural resource conservation, personal hygiene, protective coatings, odor elimination, and chemical neutralization. Breakthrough Chemistry, Inc. was formerly known as Megola, Inc. and changed its name to Breakthrough Chemistry, Inc. in July 2025. The company is based in Bonita Springs, Florida.
Stock analysis
Breakthrough Chemistry, Inc. (BKTH) currently trades at $0.0897, while our model-based Fair Value estimate is $0.0300, implying the stock looks roughly 199.0% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.
Scenario range: $0.0200 (bear) to $0.0500 (bull), the price of $0.0897 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Breakthrough Chemistry, Inc. reported revenue of $33.8K in FY2025 versus $95.6K in FY2021, a compound −22.9%/yr. Reported net income was −$46.7K in FY2025.
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).
What moves the price
The share trades about 74% below its 52-week high and 124% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −28% fair-value upside, at −67%, BKTH screens richer than that median.
Fair Value models
Bear $0.0200Fair Value $0.0300Bull $0.0500
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+78.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.4%
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.2%
’04
’05
’06
’07
’09
’10
’11
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−46.6% (2021) → −253.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Breakthrough Chemistry, Inc. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pollution & Treatment Controls · 94 stocks
P/B5.14× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 2
FUTURE (revenue growth)15· sector 11
PAST (return on equity)0· sector 18
HEALTH (low debt)0· sector 94
DIVIDEND (yield)0· sector 37
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Breakthrough Chemistry, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/BKTH
Frequently asked questions
Is Breakthrough Chemistry, Inc. (BKTH) overvalued or undervalued?
As of Jul 15, 2026, our model estimates a fair value of $0.0300 versus a price of $0.0897, about −67% upside (overvalued).
What is the fair value of BKTH?
Our model-based fair value for Breakthrough Chemistry, Inc. is $0.0300 (as of Jul 15, 2026), built from audited fundamentals. The current price: $0.0897.
What is the quality score of BKTH?
Breakthrough Chemistry, Inc. has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Breakthrough Chemistry, Inc. (BKTH)?
Our model-based price target is the fair value of $0.0300 (as of Jul 15, 2026) from 1 valuation models. Cautious scenario $0.0200, optimistic scenario $0.0500. It is a calculation from audited fundamentals, not an analyst target.
What is the Breakthrough Chemistry, Inc. stock forecast for 2026?
Our models put fair value at $0.0300, about −67% upside versus a price of $0.0897 (overvalued). Cautious scenario $0.0200, optimistic scenario $0.0500. The calculation is refreshed regularly with new filings.
What is the revenue of Breakthrough Chemistry, Inc. (BKTH)?
Breakthrough Chemistry, Inc. reported trailing-twelve-month revenue of about $19.2K (latest available figure, as of Jul 15, 2026).
What is the intrinsic value of Breakthrough Chemistry, Inc. (BKTH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Breakthrough Chemistry, Inc. it is $0.0300 per share (as of Jul 15, 2026), against a price of $0.0897. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Breakthrough Chemistry, Inc. stock overvalued or undervalued in 2026?
As of Jul 15, 2026, BKTH trades above its calculated fair value: price $0.0897, fair value $0.0300, a gap of about −67% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BKTH?
No. The price is what the market pays today ($0.0897); the fair value is what the company's own numbers justify ($0.0300). For Breakthrough Chemistry, Inc. the two are $0.0597 per share apart. That gap is exactly why we show both numbers side by side.
How much is Breakthrough Chemistry, Inc. worth?
The market values Breakthrough Chemistry, Inc. at about $2.4M (market capitalisation, as of Jul 15, 2026). Per share that is $0.0897; our models calculate a fair value of $0.0300 per share.
What do the bullish and bearish scenarios say about BKTH?
Our models span a range for Breakthrough Chemistry, Inc.: cautious scenario $0.0200, base $0.0300, optimistic $0.0500 per share (as of Jul 15, 2026, price $0.0897). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is BKTH from its 52-week high?
Breakthrough Chemistry, Inc. trades at $0.0897, about 74% below its 52-week high of $0.3500 and 124% above the low of $0.0400 (as of Sep 21, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0300 is for.
Which stocks are comparable to Breakthrough Chemistry, Inc.?
From the same area (Industrials) we also value Veralto Corporation, Zurn Elkay Water Solutions Corporation, Canmax Technologies Co, CECO Environmental Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Breakthrough Chemistry, Inc. stock attractive at the current price?
The data as of Jul 15, 2026: price $0.0897, calculated fair value $0.0300 (−67%), Quality Score 36/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BKTH calculated?
We run Breakthrough Chemistry, Inc. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0300, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Breakthrough Chemistry, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Breakthrough Chemistry, Inc. (BKTH)?
The closing price on Sep 21, 2026 was $0.0897. Our model-based fair value is $0.0300, about −67% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Breakthrough Chemistry, Inc. right now?
The price sits above even our optimistic bull case ($0.0500). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.0200 to $0.0500) leaves room in how you read the outcome.
Key figures of Breakthrough Chemistry, Inc.
How large is the market capitalisation of Breakthrough Chemistry, Inc. (BKTH)?
The market capitalisation of Breakthrough Chemistry, Inc. is $2.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Breakthrough Chemistry, Inc. (BKTH)?
Earnings per share at Breakthrough Chemistry, Inc. are $−42.18. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Breakthrough Chemistry, Inc. (BKTH)?
The net margin of Breakthrough Chemistry, Inc. is −138% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Breakthrough Chemistry, Inc. (BKTH)?
On an EBIT basis the return on assets of Breakthrough Chemistry, Inc. is −38.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Breakthrough Chemistry, Inc. (BKTH)?
The operating margin of Breakthrough Chemistry, Inc. is −528% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Breakthrough Chemistry, Inc. (BKTH)?
Revenue at Breakthrough Chemistry, Inc. is growing +2.9% versus a year earlier (3y avg +26.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Breakthrough Chemistry, Inc. (BKTH) generate?
The free cash flow of Breakthrough Chemistry, Inc. is −$58.8K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Breakthrough Chemistry, Inc. (BKTH) carry?
The net debt of Breakthrough Chemistry, Inc. is $191K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Breakthrough Chemistry, Inc. in the live analysis
One click puts Breakthrough Chemistry, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Jul 15, 2026